FIELD: organic chemistry, medicine, oncology, pharmacy.
SUBSTANCE: invention relates to new compounds of the formula (I) 
inhibiting tumor growth and angiogenesis wherein each R2 and R3 represents independently hydrogen atom (H), (C1-C4)-alkyl; each X2 and X3 represents independently (C1-C4)-perfluoroalkyl; A represents hydrogen atom (H) or a covalent bond; t represents a whole number 0 or 1 under condition that if A represents hydrogen atom (H) then t = 0, and if A represents a covalent bond then t = 1. Also, invention relates to a pharmaceutical composition and method for inhibition of the tumor growth.
EFFECT: valuable medicinal properties of composition.
32 cl, 3 sch, 5 dwg, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INHIBITION OF ANGIOGENESIS AND TUMOR GROWTH | 2001 |
|
RU2269339C2 |
| FLUORINE-CONTAINING INTEGRIN ANTAGONISTS | 2014 |
|
RU2698195C2 |
| NAPHTHYRIDIN DERIVATIVES AS ANTAGONISTS OF ALPHA V BETA 6 INTEGRIN FOR TREATING, IN PARTICULAR, FIBROTIC DISEASES | 2015 |
|
RU2692775C2 |
| NUCLEIC ACID DELIVERY SYSTEM | 2002 |
|
RU2294192C2 |
| PIPERIDINYL COMPOUNDS FOR SELECTIVE INTEGRINE BINDING | 2003 |
|
RU2333210C2 |
| META-AZACYCLIC AMINOBENZOIC ACID DERIVATIVES AS PAN-INTEGRIN ANTAGONISTS | 2016 |
|
RU2729518C2 |
| PHENYLATE DERIVATIVE, PRODUCTION, PHARMACEUTICAL COMPOSITION AND USE | 2017 |
|
RU2744975C2 |
| NEW (ACYLOXYMETHYL)ACRYLAMIDE ESTERS, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND USING THEM AS THIOREDOXIN - THIOREDOXIN-REDUCTASE SYSTEM INHIBITORS | 2011 |
|
RU2570576C2 |
| DERIVATIVE OF α-AMINOHYDROXAMIC ACID, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2265592C2 |
| (2R)-2-[(4-SULPHONYL)AMINOPHENYL]PROPANAMIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2007 |
|
RU2457201C2 |
